Health & Fitness
Dental Wound Dressings Market - Size, Trends, Outlook, and Opportunity Analysis 2018 – 2026

Dental wound dressings are small unit of medicaments, which is used in oral or maxillofacial surgery and dentoalveolar surgery to dress wounds, relieve pain, and prevent infection and to promote healing. Postoperative bleeding is major complication after tooth extraction. The dental wound dressings are used to control bleeding and protect the surface of the wound from further injury. It also cleans oral wounds created during dental surgery. The type of dressing used for wound dressing depends on various factors such as the type of injury, the size, location, and severity.


Get Sample Copy At: http://bit.ly/2F8vvn8


Dental Wound Dressings Market Driver


Increasing incidences of dental surgeries and root canal treatments are expected to boost the dental wound dressing market growth. For instance, as per Data from the National Health and Nutrition Examination Survey, for 2015–2016, the prevalence of total caries (untreated and treated) in the U.S. was 45.8% and untreated caries was 13.0% among youth aged 2–19 years. Moreover, in 2017, Capstone Clintonville Dentist surveyed that, around 15 million root canal procedures were performed in the U.S. annually.


Dental Wound Dressings Market Restraints


However, high cost of the dental surgeries is limiting the patient’s inflow in the clinics and it is expected to hamper the dental wound dressing market growth. For instance, in 2014, Canadian Academy of Health Sciences stated that Canadians spend around US$ 12 billion annually on dental services, but six million people annually avoid dentists due to high cost of dental services.


Dental Wound Dressings Market Regional Analysis


On the basis of region, the dental wound dressings market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.


North America is expected to witness significant growth in the dental wound dressing market, owing to increasing clinical trials in this region. For instance, in 2017, Medtech Startup Axio Biosolutions announced the positive results for the clinical trial of axiostat dental haemostatic dressing in patients on oral antiplatelet drugs. The study has been designed to evaluate the efficacy of Axiostat Dental Haemostatic Dressing for post extraction methods.


Europe is also expected to show significant growth for the dental wound dressings market over the forecast period, owing to increase in approvals for the products. For instance, in September 2016, NovaBone Products, a private biologics medical device company, received CE mark approval in the European Union for NovaTape and NovaPlug, dental wound dressing products. The new products are used to manage dental sores, oral ulcers, periodontal surgical wounds, suture sites, burns, extraction sites, surgical, and traumatic wounds.


Browse Complete Report For More Information @ http://bit.ly/2X4dIaT


Key players for dental wound dressings market include Sabra Dental Products., Collagen Matrix, Inc., 3M sciences Cologenesis Healthcare Pvt. Ltd., Kerr Dental., Axio Biosolutions Private Limited, Zimmer Biomet, and Novabone.


Dental Wound Dressings Market Taxonomy


By Dressing Type

Oxidized regenerated cellulose

Whitehead’s varnish

Carnoy’s solution

Bismuth iodoform paraffin paste

Zinc oxide-based dressings

Alvogyl

Collagen

By Region

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Irrigation Syringe Market - Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Irrigation syringe is an instrument used to introduce medicated fluid into the body. There are two types of irrigating syringes available including bulb irrigation syringes and piston irrigation syringes. Irrigation syringes are used to clean and remove debris from ear, eyes, and enteral part of the body.


Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2444


Irrigation Syringe Market – Drivers


Rising levels of air pollutants in the atmosphere is expected to witness significant growth in the irrigation syringe market. Air pollutants may release harmful emission or excessive quantities of substances including gases, particles, and biological molecules. These air pollutants may enter the eye and develop risk of injury in the eyes. Physician often uses the irrigation syringes to remove any foreign objects from eyes.


Moreover, increasing cases of hearing impairment due to accumulation of excessive earwax, certain infectious diseases, chronic ear infections, and exposure to excessive noise is expected to propel irrigation syringe market growth. For instance, in March 2018, as per World Health Organization data, over 5% of the world’s population, (466 million people) has disabling hearing loss.


Irrigation Syringe Market – Restraints


However, the irrigation syringe market growth may hamper due to the impact of risks associated with the usage of irrigation syringe for removal of earwax causing ear infection, perforated eardrum, or tinnitus. Furthermore, availability of advanced procedures to remove the debris from enteral part of the body may hinder the market growth. For instance, in July 2016, as per study by Department of Preventive Dentistry, Periodontology and Cariology, University of Göttingen, Germany, passive ultrasonic irrigation is more effective method than syringe irrigation for removing foreign body from enteral body part.


Irrigation Syringe Market – Regional Analysis


On the basis of region, the global irrigation syringes market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.


North America is expected to expand the irrigation syringes market size, owing to high prevalence of dental disorders such as dental caries or cavity that requires endodontic treatments. In endodontic treatment, irrigation syringes are used to facilitate the removal of microorganisms, tissue remnants, and dentin chips from the root canal. For instance, as per data from the National Health and Nutrition Examination Survey, 2015–2016, the prevalence of total caries (untreated and treated) in the U.S. was 45.8% and untreated caries was 13.0% among youth aged 2–19 years.


Key players for the irrigation syringes market include Becton Dickinson and Company, B. Braun Melsungen AG, Nipro Corporation, Medtronic plc, Smiths Group inc., Abu Dhabi Medical Devices Company, Saapp (Fzc) Llc., Ibn Sina Medical Factory, Terumo Corporation, Baxter international Inc., Dynarex, Mederen Neotech Ltd, and Cardinal Health, Inc.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/irrigation-syringe-market-2444


Irrigation Syringe Market – Taxonomy


By Product Type

Bulb irrigation syringes, Piston irrigation syringes

 

By End User

Hospitals ,Dental Clinics ,ENT specialist Clinics ,Veterinary Clinics ,Others

 

By Region

North America ,Europe ,Asia Pacific ,Latin America ,Middle East ,Africa

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Antimicrobial Susceptibility Testing Market - Share, Outlook, and Opportunity Analysis, 2018 – 2026

Antimicrobial susceptibility testing (AST) confirms susceptibility, detects resistance, and guides the selection of patient therapy. The tests can guide the physician in drug choice and dosage for difficult-to-treat infections. Antibiotic resistance is a major global health concern which requires action across the globe. It is increased due to antibiotic misuse and has become a major global health concern. Current methods for antimicrobial susceptibility testing (AST) used to probe for resistant or nonresistant (susceptible) phenotypes of pathogens, typically requires between two days to one week from the time of sample collection.


Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2449


Market Dynamics


Emergence of multidrug resistance, globally is impeding the ability to treat common infectious diseases, thereby resulting in prolonged illness, disability, and death. This is expected to increase the adoption of antimicrobial susceptibility testing during the forecast period. Moreover, the healthcare cost for patients with resistant infections is higher as compared to patients with non-resistant infections, owing to longer duration of illness, additional tests, and use of more expensive drugs. For instance, according to the World Health Organization (WHO), in 2016, around 490,000 people developed multi-drug resistant TB globally. Also, drug resistance is a major restraining factor for manufacturers that are focusing on developing drugs for HIV and malaria.


Emergence of Multidrug Resistance Worldwide Is Expected To Drive the Antimicrobial Susceptibility Testing Market Revenue


Resistance among various microbial species to different antimicrobial drugs have emerged as a major cause of public health threat. According to World Health Organization (WHO), these resistant microorganisms such as bacteria, fungi, viruses, and parasites are able to combat attack by antimicrobial drugs, which leads to ineffective treatment resulting in persistence and spreading of infections.


Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the WHO, in 2016, an estimated 490,000 people worldwide developed MDR-TB. The countries with the largest numbers of MDR/RR-TB cases were China, India and the Russian Federation.


Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is expected to drive the market growth. For instance, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to reduce the turnaround time by using genetic methods. The device can identify infectious pathogens in a matter of hours instead of days, reducing diagnostic time by 30 to 50 hours.


Key players operating in the global antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

 

 

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/antimicrobial-susceptibility-testing-market-2449

 

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Animal Model Market - Trends, Outlook, and Opportunity Analysis 2018 – 2026

Most of the biomedical researches are carried on animal model with short-term objective to study toxicity of drugs for developing new therapeutics for certain diseases. The main objective of using animal model in research is to determine how the animal will respond to the treatment. The anatomical and physiological similarities between humans and animals help the researchers to investigate novel therapies in animal models before applying it on humans. The use of animal model in research is based on fact that human diseases can affect other animal species. It is not only limited for infectious diseases but also for common diseased conditions including diabetes, hypertension, cancer, epilepsy, and others.


Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2488


Animal Model Market Outlook


Increasing number of research based on animal test to develop novel drugs is a major factor that boosts the animal model market growth. For instance, as per data reported in Annual Statistics of Scientific Procedures on Living Animals, about 3.79 million scientific procedures were carried out on protected living animals in Great Britain in 2017. Moreover, as per data in Worldwide Animal Research Statistics, in 2016, 3,789,373 vertebrates per procedure and 110,553 mammals per procedure (excluding rats and mice) have been used in research experiments conducted in the U.S.


However, rising concern for animal welfare by social and government organizations leads to use lesser number of animals in research purpose, which may hamper growth of the animal model market.


Animal Model Market Regional Analysis


On the basis of region, the global animal model market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.


Geographically, North America is expected to witness conducive growth for animal model market, owing to high presence of major market players in this region. For instance, in September 2018, Taconic Biosciences, a U.S. based company providing genetically engineered rodent model solutions, announced partnership plans with Government Scientific Source (GSS) to become the first animal model provider on general services administration contract schedule. Taconic Bioscience’s products are fit into GSS effort to support biomedical research solutions within the U.S. federal government.


Moreover, in November 2018, Jackson Laboratory, an independent, nonprofit biomedical research institution headquartered in Maine, the U.S., established a dedicated quarantine facility for the importation of JAX Mice into China. Thus, expansion of facilities by manufacturers in Asia Pacific is expected to show high growth of the market during the forecast period.


Increasing use of animal models in research for developing vaccines is another major factor, which will show significant growth for animal model market in Europe. For instance, in November 2018, in the workshop organized by EDUFLUVAC consortium, a European Union funded project, coordinated by the European Vaccine Initiative, experts from influenza vaccine community gathered to discuss the current knowledge and future perspectives for testing broadly reactive influenza vaccines in animal models. The workshop has been organized for summarizing the outcome of “Experimental animal models for universal influenza vaccines” project.


Key players in the animal model market include Charles River Laboratories International, Inc., Horizon Discovery Group plc, The Jackson Laboratory, Trans Genic Inc, Taconic Biosciences, Inc., Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Harbour Antibodies BV, Envigo CRS SA, Ingenious Targeting Laboratory, and Transposagen Biopharmaceuticals, Inc.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/animal-model-market-2488


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Proteomics Market - Size, Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Proteomics is a study of large scale proteomes. Proteomes are entire complements of protein expressed by a tissue, cell or organism. Proteomics aims to interpret the roles of large number of proteins made from combining 22 genetically-encoded amino acids. It helps to understand the structure, function, and interactions of the entire protein content in a specific organism. It is used to investigate protein expression, rates of protein production, degradation, modification of protein, protein movements in subcellular compartments, and protein-protein interaction.


Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2493


Global Proteomics Market: Drivers


Key players in the market are focused on introducing new and improved proteomics techniques, which is expected to boost the proteomics market growth. For instance, in September 2017, Bruker Corporation launched timsTOF Pro system for parallel accumulation and serial fragmentation (PASEF) mass spectrometry— using proprietary trapped ion mobility spectrometry (TIMS) technology—to offer efficient data acquisition speed for shotgun proteomics.


Moreover, in October 2018, Bruker Corporation introduced a next-generation workflow for the timsTOF Pro mass spectrometer at Human Proteome Organization (HUPO). The platform for timsTOF Pro workflow includes large-scale, reproducible, and accurate collision cross section (ccs) values for tryptic peptides, fastpro, and ccs-based lipidomics workflow.


Moreover, in 2017, Diagenode, a provider of complete solutions for epigenetics research and sample preparation, in collaboration with PreOmics GmbH, developer and provider of innovative tools for MS-based proteomics, launched new streamlined sample preparation solution for proteomic analyses. The new solution was developed by combining PreOmics in-StageTip Kit (iST Kit) and the Diagenode Bioruptor sonication system to clean peptides for mass spectrometry (MS) analysis.


Global Proteomics Market: Regional Analysis


On the basis of region, the global proteomics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.


North America is expected to account for the largest market share in the proteomics market over the forecast period. The market growth is attributed to increasing collaboration and partnership activities by key players in this region. For instance, in November 2018, Thermo Fisher Scientific Inc. and Symphogen entered into a two-year collaborative partnership to deliver validated platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. Under this agreement, Symphogen would have access to Thermo Fisher’s Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC-MS/MS) system with BioPharma Option for creating, testing, and validating the platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures. Moreover, Symphogen will focus on the development of automated multi-attribute method (MAM) workflows for monitoring critical quality attributes of proteins using high-resolution accurate-mass mass spectrometry in a quality control environment.


Increasing government initiatives to promote research and development in proteomics, genomics, and bioinformatics is expected to propel Asia Pacific proteomics market growth during the forecast period. For instance, the 13th International Conference on Proteomics, Genomics, and Bioinformatics will be held on May 10-11, 2019 in Tokyo, Japan. The theme of the conference will be ‘Leading Edge Innovations in Life Sciences’ and the objective will be to explore the recent advancements and new methodologies that can be applied to the research to make proteomics and bioinformatics more advance. Target audience for the upcoming conference can be health professionals, researchers and scientists, management/business leaders and/or agents, government/non-government community groups or individuals, professors, psychiatrist, and therapists.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/proteomics-market-2493


Key players operating in the global proteomics market include, Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics Inc., PerkinElmer, Inc., Biognosys Inc., Bruker, Cell Signaling Technology, Inc., Newomics, Inc., Proteome Sciences, Applied Biomics, Inc., Courtagen Life Sciences, Inc., Xcelris Genomics., Center for Genomic Sciences, and Sera Prognostics, Inc.


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Aromatherapy Market - Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Aromatherapy is a holistic healing treatment that uses natural plant extracts to promote health and well-being. It’s also called as essential oil therapy, as essential oils are major components of aromatherapy. Aromatic essential oils help to improve the health of the body, mind, and spirit. It enhances both physical and emotional health.


Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2517


Aromatherapy is thought of as both an art and a science. Aromatherapy has numerous benefits some of them include management of pain, improve sleep quality, reduce stress, depression and anxiety, treat headaches and migraines, ease discomforts of labor, fight bacteria, virus or fungus, and boost immunity. Most popular essential oils of aromatherapy are eucalyptus, lavender, lemon, lemongrass, rosemary, geranium, chamomile, and tea tree oil.


Global Aromatherapy Market: Drivers


The aromatherapy market revenue is expected to witness significant growth, owing to its increasing adoption and wide range of application. Aromatherapy along with essential oils are used to combat the side effects of chemotherapy such as nausea, vomiting, anxiety, and depression. For instance, a study published in the journal Oncology Nurse Advisor in May 2018, stated that patients who had undergone brachytherapy - a treatment that delivers a targeted dose of radiation to tumors inside the body - experienced a 60 percent reduction in pain and a 20 percent reduction in anxiety after receiving essential oil aromatherapy and 30 minutes of foot reflexology therapy prior to their treatment sessions.


Furthermore, aromatherapy is widely used in skincare and beauty products, owing to increasing demand for herbal products, which contributes to aromatherapy market growth. For instance, according to studies published in National Center for Biotechnology Information (NCBI) in 2018, acne treatment cream with combination of 20% propolis, 3% tea tree oil, and 10% Aloe Vera reduces acne efficiently in 15-30 days, owing to antibacterial and antifungal effects of tea tree oil.


Global Aromatherapy Market: Restraints


Essential oils are only for topical use and inhalation use, essentials oils can be poisonous if swallowed or used improperly. Essential oils are very concentrated, they are always used in minimum amount and diluted with carrier oil. The aromatherapy market growth is hampered, owing to improper use, which shows side effects such as rashes, asthma attacks, headaches, allergic reactions, skin irritation, and nausea. An experimental study was conducted in Taipei Medical University in 2012, where 100 healthy people were exposed to a room, which contained tiny droplets of essential oil of bergamot infused in air for 2 hours. After 75 minutes, the condition of people began to deteriorate, the blood pressure, heart rate dropped and people started to feel sick.


According to International Fragrance Association (IFRA) 2017 report, some oils should be completely avoided due to their toxicity. IFRA has banned many essential oils such as almond (bitter), aniseed, boldo, calamus, camphor, cassia, horseradish, mugwort, mustard, pennyroyal, rue, sassafras, savin, tansy, thuja, wintergreen, and wormwood till date.


Global Aromatherapy Market: Regional Analysis


North America is expected to hold the dominant position in the aromatherapy market over the forecast period, owing to presence of major companies in the U.S., which include doTERRA International, Young Living Essential Oils, Frontier Natural Products Corporation, Rocky Mountain Oils, Mountain Rose Herbs, Edens Garden, and Plant Therapy.


Asia Pacific is anticipated to witness significant growth due to increasing demand for use of essential oils for treating burns, scars, and related infections. According to Asian Pacific Journal of Tropical Biomedicine 2015 reports, Eucalyptus and Lavender essential oils are widely used for soothing burns and helping prevent burns from becoming infected, owing to anti-microbial and anti-inflammatory property of the oils. It is also used to treat other skin problems such as cuts, lice, and insect bites.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/aromatherapy-market-2517


Global Aromatherapy Market: Competitive Landscape


Key players operating in the global aromatherapy market include doTERRA International, Eden Garden, Young Living Essential Oils, Frontier Natural Products Corporation, Rocky Mountain Oils, Mountain Rose Herbs, Plant Therapy Inc., Thann-Oryza Co. Ltd., G Baldwin & Co., Ouwave Aroma Tech Co., Ltd., RyohinKeikaku Co. Ltd. (Muji), and Zija International, and Plant Therapy Essential Oils.


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

DNA Repair Drugs Market – Trends, Outlook, and Opportunity Analysis, 2019 – 2026

DNA can be damaged due to endogenous factors (oxidation) or exogenous factors (UV radiations or viruses), but our cell can identify and repair the damage. However, when the repairing mechanism of the cell fails, it leads to dysfunctionality or mutations in the DNA of the cell. It can also lead to abnormal growth of cells, i.e., cancer. Such irreparable damage can be treated with DNA repair drugs such as poly ADP-ribose polymerase inhibitors (PARP). PARP blocks the activity of ADP-ribose polymerase proteins, thus preventing the replication of cancer cells.


Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2617


Global DNA Repair Drugs Market Drivers


Increasing collaboration and acquisition activities are expected to boost the global DNA repair drugs market growth. For instance, in January 2017, Merck KGaA entered into a licensed agreement with Vertex Pharmaceuticals Inc., for four research developments on approaches to cancer. The reason for the partnership was to strengthen Merck’s area of DNA damage response and immuno-oncology. Furthermore, in February 2016, Onxeo, an orphan oncology therapeutics company, acquired DNA Therapeutics, a biopharmaceutical company for its DNA repairing technology for treatment of cancer. This technology consists of a signal interfering DNA molecule (siDNA), and Onxeo S.A. intends to develop this technology as a potential treatment option for cancer. Such partnerships are expected to propel the global DNA repair drugs market growth.


Moreover, frequent research and development activities are expected to propel the global DNA repair drugs market growth. For instance, in October 2018, Pfizer began conducting a trial of talazoparib drug for the treatment of triple negative breast cancer. Currently, it’s in second phase of clinical trial and it is a type of monotherapy. Furthermore, there are many other products that are in pipeline. For instance, in February 2019, BeiGene began with its clinical trials of pamiparib for the treatment of metastatic prostate cancer. The trial of pamiparib is currently in its second phase. Such key researches are expected to boost the global DNA repair drugs market growth.


Global DNA Repair Drugs Market Regional Analysis


North America is expected to hold a dominant position in the global DNA repair drugs market. Factors such as increasing research and development activities are expected to have an influence on the North America’s DNA repair drugs market growth. For instance, in 2017, Harvard Medical School and University of South Wales conducted a study on DNA repair drugs for treatment of radiation damage that causes cancer. They have discovered the mechanism that weakens the system of our cell’s capability to repair the damages. They developed a drug, which was tested on mice and the mice were successfully able to retrieve the cell functions. The successful development of such researches is expected to propel the global DNA repair drug market growth.


Global DNA Repair Drugs Market Restraints


Failure of drugs in late stages of clinical trials has hampered the global DNA repair drugs market growth. For instance, in April 2017, Veliparib, a product by AbbVie was withdrawn from both the clinical trial studies. One of the clinical trial study involved the drug’s efficacy on breast cancer and other for lung cancer. Veliparib was treated with a combination of chemotherapy for both, lung and breast cancer treatment. Both of the trials were withdrawn at its third phase. Such failures may hinder the global DNA repair drugs market growth.


High costs of drugs are expected to hinder the global DNA repair drugs market growth. Manufacturers are focused on offering a highly effective drug, thus investing more into research and development activities. This factor further adds up into final cost price of the product. For instance, a Lynparza tablet of 50 mg costs around US$ 32. Such high cost would be an obstruction in the developing regions such as Africa, Latin America, and Asia-Pacific for the global DNA repair drugs market growth.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/dna-repair-drugs-market-2617


Global DNA Repair Drugs Market Key Players


Some of the major players operating in the global DNA repair drugs market include 4SC AG, Artios Pharma, Johnson & Johnson Service Inc., GlaxoSmithKline plc, Genentech, Inc., Sierra Oncology Inc., AstraZeneca, Karyopharm Therapeutics, Jiangsu Hengrui Medicine Co., Ltd., and Merck KgaA.


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Pregnancy Testing Devices Market - Trends, Outlook, and Opportunity Analysis, 2019 – 2026

Pregnancy testing devices are medical devices that help in identifying the possibility of pregnancy. Pregnancy testing devices analyze the samples of women’s blood or urine for the presence of human chorionic gonadotrophin (HCG). The device detects tiny amount of HCG, a female pregnancy hormone that increases during early stages of pregnancy in female body. The urine pregnancy test kit provides qualitative results i.e. positive or negative. It contains the test strip, which is directly exposed to the potential women’s urine. The blood test kit is the most sensitive pregnancy test. The test allows the clinician to detect exact levels of HCG in women’s blood, which is based on HCG molecules bound on the test strip.


Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2635


Global Pregnancy Testing Device Market Drivers


Rise in demand for the fast, self-contained tests results, growing age of first pregnancy, continuous technological advancement, and attractive product features such as smartphone app connectivity in pregnancy test device are likely to drive growth of global pregnancy test device market over the forecast period. Moreover, growing awareness regarding the availability of pregnancy testing devices and utilization of self-detection pregnancy device, increased healthcare expenditure, rise in disposable income, and increase in prevalence of teenage pregnancy also stimulate the market growth. In April 2015, Abbott Laboratories received the U.S. FDA approval for its I-STAT TOTAL HCG test for rapid and accurate detection of HCG hormone in pregnant women.


Moreover, as compared to lab tests, which are more time consuming and expensive, pregnancy testing devices provides fast results in less expense. However, the accuracy of pregnancy test device is less than the lab tests. According to the World Health Organization (WHO), in 2015, there were 40% cases of unintended pregnancy and 10% cases of teenage pregnancy. Rise in unintended pregnancies is expected to create the demand for the pregnancy testing devices. For instance, according to Lancet Global Health, study conducted in 2015, 70 unintended pregnancies per 1000 women between age group 15-49 years occurs in India.


Moreover, various novel devices are launched considering women’s health and hygiene, which are expected to facilitate market growth. For instance, in 2019, Deep Bajaj, Founder of PeeBuddy, India’s first design patent protected female urination device, launched the paper based pregnancy test PregRX. With PregRX, women can simply pee and instantly check their pregnancy status.


However, due to availability of too many options in the market and device-related issues can hinder growth of global pregnancy testing device market.


Global Pregnancy Testing Device Market - Regional Insights


North America holds dominant position in the global pregnancy testing device market, owing to high healthcare expenditure and awareness programs taken by companies regarding the effective usage of pregnancy testing devices. For instance, in December 2017, Lia diagnostics, U.S., developed a flushable pregnancy test that is made from sustainable biodegradable materials. The company claims that this pregnancy kit will be available over the counter and is the world’s first and only flushable, biodegradable pregnancy test. Europe is expected to witness higher growth rate in the forecast period, owing to high adoption of digital pregnancy detecting device over the forecast period. Latin America is also an emerging market, owing to the increasing awareness regarding benefits of pregnancy detection in early stage and affordability of pregnancy detection kits.


Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2635


Global Pregnancy Testing Device Market - Competitive Landscape


Some of the key players operating in the global pregnancy testing device market include Piramal Enterprises, Alere Inc., Prestige Brands Holdings Inc., Quidel Corporation., Procter and Gamble Co., Cardinal Health, and Confirm Biosciences.


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Spine Surgery Devices Market – Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Spinal injuries can occur due to damage of vertebrae, ligaments, or discs of the vertebral column. The higher is the injury on the vertebral column, more effect of the injury is likely to occur as it is nearer to the brain. Such injuries can be treated by surgical procedures. However surgeries do not treat damages, but can reduce the deformity, relieve the pain and help in alignment of the spine (if fractured). The devices of the surgery that are required depend on the approach of the treatment chosen by the surgeon.


Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2645


Global Spine Surgery Devices Market Drivers


Frequent approvals by regulatory bodies of novel surgical devices used in spinal injury is expected to drive the global spine surgery devices market growth. For instance, in September 2018, Meditech Spine LLC received approval by the U.S. Food and Drug Administration (FDA) to market its product Cure Opel – C system. Cure Opel – C system is an additional technology to its already existing product Cure ACP system and Talos – C (HA) Interbody System. It provides a unique lock mechanism, which prevents backing out of screws once fixed in the vertebral column.


Furthermore, in January 2017, Camber Spine Technologies, LLP received an approval by the U.S. FDA for its product Siconus SI Fusion Screw System. It provides support and fixation to larger bones like sacrum. Camber Spine Technologies developed this system with the partnership of Institute for Musculoskeletal Science & Education. Such approvals of novel devices by regulatory bodies is expected to propel the global spine surgery devices market growth.


Furthermore, activities such as collaborations, partnerships, mergers, and acquisitions by manufacturers are expected to elevate the global spine surgery devices market growth. For instance, in May 2019, Medtronic plc, a medical device company acquired Titan Spine LLC, a manufacturer of interbody fusion devices, so as to expand its product portfolio related to spinal surgery devices. Medtronic plc is expected to buy Titan Spine LLC’s full Spine portfolio, which includes titanium–based interbody fusion devices. Hence, such acquisitions are expected to accelerate the global spine surgery market growth.


Global Spine Surgery Devices Market Regional Analysis


North America is expected to hold a dominant position in global spine surgery devices market over the forecast period. Factors such as high prevalence of spinal cord injuries is expected to drive the North America’s spine surgery market growth. For instance, according to National Spinal Cord Injury Statistical Center, the U.S. had around 17,700 new cases of spinal cord injury and the number of people living with the spinal cord injury were found out to be around 288,000, in 2018. Hence, increase in rate of spinal cord injuries would increase the demand for more surgeries, in turn supporting the global spine surgery devices market growth over the forecast period.


Global Spine Surgery Devices Market Restraints


Complications in surgical procedures related to spinal injuries may influence the adoption of these surgeries and thus, hampering the global spine surgery devices market growth. According to National Health Services (NHS), U.K., all surgeries are associated with some kind of risks. For instance, in lumbar decompression surgery (Laminectomy) there is a risk of infection at the location of invasion. It also includes risk of blood clots, accidental damage to the nerves, loss of vision, and facial sores. Hence, this factor is expected to hinder the global spine surgery devices market growth.


Global Spine Surgery Devices Market Key Players


Some of the major players operating in the global spine surgery devices market include Zimmer Biomet Holdings Inc., Stryker Corporation, DePuy Spine Inc., Medtronic plc, Globus Medical Inc., Smith and Nephew plc, Arthrex , Inc., Paradigm Spine LLC, Meditech Spine LLC, and Alphatech Spine Inc.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/spine-surgery-devices-market-2645


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Laboratory Refrigerators and Freezers Market - Trends, Outlook, and Opportunity Analysis, 2019 – 2027

Laboratory refrigerators and freezers are used for preservation of specimen samples, blood samples, blood plasma, and other products including vaccines, syringes, etc. giving it a broad range of applications. These are highly sterilized and maintained at the required standards for prevention from bacterial or any other contamination. They are supposed to maintain a constant temperature, in order to minimize the risk of contamination and explosion (in case of volatile products). A refrigerator or freezer typically contains – condenser, compressor, evaporator, and expansion valve. Freezer is used when the products are to be maintained at a temperature below the freezing point.


Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2652


Global Laboratory Refrigerators and Freezers Market Drivers


Adoption of strategies such as collaboration, partnerships, merger, and acquisitions by the key players is expected to drive the global laboratory refrigerators and freezers market growth. For instance, in May 2018, Phononic, Inc., partnered with Thermo Fischer Scientific, a biotechnology product development company for creating an exclusive product line in healthcare and life sciences. This agreement also includes development of Thermo Fischer Scientific‘s TSX 505 series of laboratory refrigerators. Hence, such partnerships are expected to accelerate the global laboratory refrigerators and freezers market growth.


Furthermore, key players are constantly introducing new product into the market, which is expected to propel the global laboratory refrigerators and freezers market growth. For instance, in June 2016, Phononic Inc. launched a product, medical grade under-counter refrigerator, which was added to its Evolve brand. It is used for storage of pharmaceutical drugs, vaccines, and medical devices. The refrigerator provides high stability in regulating temperature and a monitoring software. It also has batter back-up facility and noise producing level is very low (less than 35 decibels).


Furthermore, in February 2019, Panasonic Health Co. launched a new refrigerator, which is going to be used for preservation of pharmaceutical drugs, vaccine, high–value samples and specimens. It has – 300C freezer (free natural refrigerants used) and invertor compressor, which helps in reduction of power consumption. Hence, introduction of new products is expected to, drive the global laboratory refrigerators and freezers market growth.


Global Laboratory Refrigerators and Freezers Market Regional Analysis


North America is expected to hold a dominant position in the global laboratory refrigerators and freezers market, owing to increase in number of blood banks, influencing positively North America’s laboratory refrigerators and freezers market growth. According to Americas Blood Centers, there are over 600 blood collection centers present in the U.S., 2018, and these blood collection centers are expected to require more number of laboratory refrigerators and freezers for storing the blood plasma and other products. Hence, this may increase the demand for laboratory refrigerators and freezers in North America and thereby, driving the global laboratory refrigerators and freezers market growth.


Global Laboratory Refrigerators and Freezers Market Restraints


Manufacturers are constantly developing new products in laboratory refrigerators and freezers. This further adds up into final cost, making these products expensive, which may hinder the global laboratory refrigerators and freezers market growth. For instance, one TSX Series Ultra Low Temperature Freezer, a product of Thermo Fischer Scientific costs around US$ 21,908. Such high costs of laboratory refrigerators and freezers may lead to lesser adoption in emerging economies and thereby, restricting the global laboratory refrigerators and freezers market growth.


Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2652


Global Laboratory Refrigerators and Freezers Market Key Players


Some of the major players operating in the global laboratory refrigerators and freezers market include, Thermo Fischer Scientific, Phononic Inc., Philipp Kirsch GmbH, Haier Biomedical, Panasonic Healthcare Co., Ltd., VWR Corporation, Eppendorf AG, Bionics Scientific Technologies Ltd., Helmer Scientific, and Aegis Scientific Inc.


About Coherent Market Insights


Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us


Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Electrophoresis Market - Trends, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Electrophoresis is a technique to separate DNA, RNA, and protein based on their size/mass and/or electrical charge. The technique is used in many research applications of molecular biology to examine experimental outcomes and in some cases to isolate and purify samples, before proceeding to a subsequent step. Electrophoresis plays a vital role in the separation of nucleic acids and proteins in the field of proteomics and genomics.


Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2666


The global electrophoresis market was valued at US$ 2,263.3 million in 2017, and is expected to witness a CAGR of 5.7% over the forecast period (2018 – 2026).


Increasing research and development activities in pharmaceutical and biotechnology sector is expected to drive the electrophoresis market growth


According to the Pharmaceutical Research and Manufacturers of America (PhRMA) 2018 report, biopharmaceutical companies based in the U.S. invested around US$ 90 billion in R&D in 2016. Electrophoresis has application in various fields ranging from healthcare to forensic science. For instance, hemoglobin electrophoresis tests blood samples and determines blood disorders such as sickle cell anemia.


Various complex biological molecules such as antibiotics, vitamins B12, and proteins can be separated efficiently by electrophoresis due to charge difference among the mixtures. Electrophoresis is also used in preparation of antibiotic medicines and testing drugs for resistance to pathogens. The technique is used in the purification and analysis of different types of vaccines such as Hepatitis and influenza.


Market Dynamics


Increasing research and development activities in the field of proteomics, genomics, and drug discovery is the major factor driving the global electrophoresis market growth. Increasing research in genomics and rising initiatives, investments, grants, and funds by government in the field genomics is creating growth opportunities for industry players. For instance, in 2016, National Human Genome Research Institute launched a new initiative Genes, Environment and Health Initiative (GEI) to support the research that lead to the understanding of genetic contribution and their effect in common diseases.


Rising chronic diseases and increasing geriatric population are propelling demand for development of effective drugs, which is creating opportunity for industry players. Moreover, electrophoresis is also used in forensics to compare DNA, in medical laboratories to perform genetic testing, and in microbiology labs to identify microorganisms. However, requirement of external power supply for running electrophoresis unit and contamination of selenium and vanadium can negatively impact growth of electrophoresis market during the forecast period.


Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/electrophoresis-market-2666


Electrophoresis Market - Competitive Landscape


Key players operating in the global electrophoresis market include Agilent Technologies, Bio-Rad Laboratories, C.B.S. Scientific Company, Inc., Danaher Corporation, GE Healthcare, Harvard Bioscience, Inc., Hoefer Inc., Lonza Group Ltd., Merck Millipore, PerkinElmer, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., and Qiagen N.V.

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Digital Stethoscope Market - Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Digital Stethoscope is a modern technology device that transforms acoustic sound into electronic signals, which further can be amplified for ideal listening. Electronic signals can be further digitalized and processed to transmit them in to a laptop or personal computer. The digital stethoscope consists of three different modules i.e. data acquisition, pre- processing, and signal processing. Data acquisition model consists of piezoelectric sensor and microphone. This module is responsible for buffering, amplification, and filtering of auscultated sounds whereas it is also responsible for conversion of acoustic sound to digital signal. Pre-processing module is responsible for filtering digital signals to remove any artifacts. Signal processing module helps in packaging of information in high order classification and helps in clustering of the data for a diagnostic decision. Currently available digital stethoscopes allows user to select different frequency response modes, which allows listener to efficiently examine sounds from lungs, heart, and other body parts. For instance, the 3M Littmann Stethoscopes Range consists of piezoelectric sensor, which helps to reduce ambient noise using adaptive noise canceller and allows amplification of sound up to 24 times. An advanced digital stethoscope helps to stream heart sounds on smart phones as well.


Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1711


Digital Stethoscope Market Drivers:-


Advancement in technology such as development of electronic stethoscope with Bluetooth wireless capability is expected to be one of the major drivers of growth of digital stethoscope market. Digital stethoscopes offer various advantages as compared to the manual stethoscopes. One of the major advantages is that digital stethoscopes have the ability to amplify sounds, as well as observe the received sounds on a visual display. Some Stethoscopes are also capable of recording and replaying the captured video or audio, which helps practitioners or physicians to maintain patients’ medical data. A new product, Steth IO has been launched by Steth IO, a U.S.-based company, in April 2018. Steth IO is a smart phone based digital stethoscope. It can be used exclusively on iPhones (module 6 and above). This device helps doctor to listen and also measure heart rates or lung sounds just by operating an app on phone and by placing it close to the patient’s chest. This device was approved by Food and Drug Administration (FDA) in 2016. This product does not require batteries or chargers as it draws power directly from the iPhone. This device also helps physicians to keep a record of the patient’s medical data, add flag clips, or notes within the recordings.


Other factors such as increasing number of patients suffering from cardiovascular disorders, improved diagnosis due to advantages provided by digital stethoscope, and increasing awareness among population regarding use of digital stethoscope are expected to boost growth of the digital stethoscope market. According to a study conducted by Centers for Disease Control and Prevention (CDC), in 2017, in the U.S. around 735,000 people are suffering from cardiovascular disorders, which is in turn fueling growth of the market.


However, high cost of the digital stethoscope as compared to conventional stethoscope may hinder growth of the market.


Digital Stethoscope Market Regional Analysis:-


North America is expected to hold dominant position in global digital stethoscope market, owing to the availability of innovative products in the region. In 2009, the 3M Company, a U.S.-based company launched first electronic stethoscope with Bluetooth wireless capacity. 3M Littman Electronic Stethoscope model 3200 paired with new zargis medical software helps in detecting heart murmurs. Bluetooth technology of this device helps to transfer lungs, heart, and other sounds of the body directly to the software for further analysis. This device consists of 2 software i.e. Zargis Cardio scan software and Zargis Steth Assist Software. Zargis cardio scan software easily pairs with the device to help the doctor diagnose four main cardiac sites, after one minute the device provides report about the patient’s heart condition indicating all the problems observed. Europe is expected to witness significant growth over the forecast period, owing to launches of novel products in the region. For instance, in 2015, Ekuore a Spain-based company launched eKuore Pro Stethoscope, a wireless stethoscope. The company also has a product named eKuore stethoscope for hearing loss, which can be used by doctors who are have a problem in hearing or are deaf, as they have hearing aids connected to them.


Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1711


Digital Stethoscope Market Key Players:-


Major players operating in digital stethoscope market include Eko Devices, FarmaSino Pharmaceuticals, Contec Medical Systems, Qufu Longer Care Meditech Limited, Exanovo Group, Think Labs Medical LLC, Sensi Cardiac, and 3M. Eko Devices has two digital stethoscope devices named as CORE and DUAL. CORE has 40x sound amplification, which can work with all stethoscopes and delivers loud and clear sound of heart and lungs. DUO is a combination of EKG and electronic stethoscope. It is a portable and hand held device, which provides review of the heart sounds and rhythms in an accompanying software.


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Botulinum Toxin Market - Trends, Industry Insights, and Forecast till 2026

Botulinum toxin is a product produced by naturally occurring Clostridium botulinum bacteria. This bacteria is found in soil and marine sediments and can produce harmful neurotoxin botulinum toxin. Botulinum toxin is a ‘blocking agent’ which inhibits the release of certain neurotransmitters, specifically acetylcholine, from the endings of the motor nerves. There are about eight types of botulinum toxin named from type A to H. Botulinum toxin type A and botulinum toxin type B are majorly used in cosmetic procedures for the treatment of various facial conditions, its commercially marketed under the brand name Botox. Botulinum toxin type A and B are also used in medical applications for treatment of various diseases such as dystonia, chronic migraines, and spasticity.


Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/1518


Botulinum Toxin Market: Drivers


Frequent approvals of novel botulinum toxin products for different indications are expected to drive growth of the Botulinum toxin market in near future. For instance, in 2016, Ipsen S.A. received the U.S. Food and Drug Administration (FDA) approval for its Dysport (abobotulinumtoxinA) injection indicated for the treatment of pediatric lower limb (PLL) spasticity in children of age two years and older. In 2017, company received the FDA approval for same product to use in adults. In 2017, Allergan plc. received FDA approval for BOTOX Cosmetic (OnabotulinumtoxinA) for new indication in forehead lines, and previously the product has been approved for the treatment of , crow's feet lines, and glabellar lines. With this approval company has expanded the indication of its product in the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults. In 2014, Allergan Inc. received approval for its BOTOX (Botulinum toxin type A) from Medicines and Healthcare Products Regulatory Agency (MHRA) in U.K. BOTOX was approved in the U.K. for treatment of ankle disability due to lower limb spasticity associated with stroke in adults. In 2016, Daewoong Pharmaceutical Co., Ltd received approval for its botulinum toxin Nabota in Mexico and India. Nabota was introduced by Daewoong Pharmaceutical Co., Ltd in South Korea in 2014. In 2015, Merz North America, the U.S. subsidiary of the global Merz Pharma Group, received U.S. FDA approval for Xeomin (incobotulinumtoxinA) indicated for the treatment of upper limb spasticity (ULS) in adult patients. Furthermore, increasing trend of botulinum toxin in cosmetic procedures is also expected to increase the growth of botulinum toxin market in near future. For instance, according to a report published by American Society of Plastic Surgeons in 2016, around 7,056,255 cosmetic minimally-invasive procedures were performed with Botulinum toxin Type A (Botox, Dysport, and Xeomin), there was an increase of 4% in procedures as compared to 2015. Increasing number of procedures with botulinum toxin along with increasing approved indication is expected to drive growth of the global botulinum toxin market.


Botulinum Toxin Market: Regional analysis


North America is expected to hold a dominant position in the global botulinum toxin market, owing to increasing trend of cosmetic procedures in the region. For instance, according to a report published by American Society of Plastic Surgeons in 2016, around US$ 16.4 billion was spent on cosmetic procedures in the U.S. and in 2017, around 7.2 million botulinum injections were used in the U.S. for cosmetic procedures. Increasing number of cosmetic procedures in the key region of North America is expected to drive the growth of the botulinum toxin market in near future. Furthermore, Asia Pacific is expected to show rapid growth in botulinum toxin market, owing to increasing R&D and approval of novel products in China. For instance, in January 2018, Daewoong Pharmaceutical Co. Ltd., a Korean company, received approval from the Chinese authorities to conduct clinical trials for botulinum toxin Nabota in China.


Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1518


Botulinum Toxin Market: Key Players


Key players operating in global botulinum toxin market includes Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH and Co. KGaA, US Worldmed, LLC, Lanzhou Institute of Biological Products Co. Ltd., Revance Therapeutics, Inc., and Daewoong Pharmaceutical Co., Ltd. Major players in market are involved in strategic collaborations to develop new products. For instance, in February 2018, Mylan N.V. and Revance Therapeutics, Inc. underwent strategic collaboration and license agreement for the development and commercialization of a proposed biosimilar to BOTOX (onabotulinumtoxinA). Furthermore, key players are focusing on receiving approvals of its product in key market to expand their presence in global market. For instance, in February 2018, Medytox Inc. filed a new drug application with the China Food and Drug Administration (CFDA) to its botulinum neurotoxin product Meditoxin in China.


About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Global Digital Radiography Market - Trends, Analysis, and Forecast till 2024

Increasing health consciousness and growing awareness about the same are leading to higher footfalls in diagnostic laboratories. This is contributing towards overall growth of diagnostics market. Furthermore, digitization in healthcare sector is easing patient diagnosis, providing accurate and faster test results. X-ray being the most conventional and effective diagnostic tool, digitization in the X-ray system has gained a strong foothold in diagnostic laboratories across the globe. Also, with more research in this field, introduction of mobile digital x-ray systems have further improved the global digital radiography market outlook. Digital radiography finds application in dental, chest imaging, orthopedic, and mammography. Ease of operating with mobile systems, increasing demand for portable and mobile equipment is growing rapidly in digital x-ray market. The rapidly declining user base of analog systems would further contribute towards growth of digital radiography market.


Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/151


The global digital radiography market was valued at US$ 7,538.8 million in 2015 and is expected to witness a moderate CAGR of 5.9% during the forecast period (2016 – 2024).


 

Market Dynamics


Rise in number of accidents, growing prevalence of dental disorders, and increasing prevalence of breast cancer are some of the vital factors that are expected to fuel growth of the digital radiography market in the near future. Novel products and diagnostic systems in dentistry are projected to reshape the world dentistry market in the near future, with the utilization of the digital radiography technique expected to favor early detection of teeth related disease such as caries and cavities. This in turn is projected to favor growth of the digital x-ray market over the forecast period. According to Straumann CMD 2012, digitalization will further change value chain & workflows for dentists and laboratories along with the provision of digital scanning, which will provide a 3D-view of the oral situation. Furthermore, rising number of bone disorders due to increasing elderly population is expected to favor the digital radiography market over the forecast period.


Market Taxonomy


This report segments the global digital radiography market on the basis of application, device type, portability, end user, and geography. On the basis of application, the market is categorized into chest imaging applications, orthopedic applications, cardiovascular imaging applications, dental applications, mammography applications and other applications. On the basis of device type, the market is categorized into direct radiography and computed radiography, in which direct radiography is further divided into charge coupled device (CCD) and flat panel detector. On the basis of portability, the market is categorized into fixed digital radiography systems, retrofit digital radiography systems and mobile digital radiography systems. On the basis of end-user, the market is categorized into diagnostic centers, hospitals and dental clinics. For comprehensive understanding of market dynamics, the global gynecological devices market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.


Rising aging population to increase consumer base of digital radiography market

Aging results in weakening of the immune system. Thus, the elderly population is at a major risk of chronic diseases such as chronic respiratory disease, cardiovascular disorders, dental issues, and orthopedic disorders. According to the World Population Prospects report (2015) by the United Nations (UN), the global population aged 60 years and above is projected to increase by 56% from 901 million in 2015 to 1.4 billion by 2050. This growth rate is faster than the growth of population in other age groups. The report mentions that Japan is home to world’s most aged population (33% in 2015). Aging population exerts pressure on the health budget of the nation leading to increase in demand for cost-effective solutions. This in turn, would generate a more positive digital radiography market outlook.


Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/151


Key companies covered as a part of this study include 3DX-Ray, Anritsu Infivis, Bosello High Technology, COMET, GE Healthcare, Mettler-Toledo International, Nikon, North Star Imaging, VJ Technologies, Fujifilm Holdings, Philips Healthcare, Shimadzu Corporation, Toshiba Medical System Corporation, Carestream Health

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Smart Healthcare Products Market - Size, trends, and Forecast to 2026

Smart healthcare products are technology-based products, which offers benefit of advancements in IT hardware and software for better healthcare delivery. They are emerging set of products with positive prospects in near future due to increasing amalgation of information technology in health offerings services. They could save on ever-growing health care cost by imparting operational efficiency and could bring better clinical outcome with monitoring tools such as smart pill etc.


Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1982


Market Dynamics


Increasing number of people above age 60 worldwide leads to higher requirement of healthcare needs with more emphasis on long term care and chronic disease care, which is one the major drivers for growth of the market. Developed economies such as U.S. and Europe are witnessing high number of population ageing 65 and above. According to the U.S. Census Bureau’s report of 2017, around 47.8 million people were aged 65 and older in the U.S. in 2015 accounting for 14.9% of the total population, a 1.6 million increase from 2014. Europe is currently having highest 65 years and above age population, which is 25% of entire population, according to the Population Prospect Report of the United Nations published in 2017. Smart pill and smart syringe would prove to be important smart healthcare products platform for this population. Another important factor for growth of the smart healthcare products market would be high technological penetration in the smart healthcare products market domain. For instance, cloud-based electronic medical record, which could be shared amongst entire healthcare stakeholders would make entire health operation smooth and efficient.


Increasing number of geriatric population and high prevalence of chronic disease for various parameters is expected to propel growth of the smart healthcare products market


Population across globe is slowly observing growth in median age with higher number of people crossing age bracket of 60 and above. According to the Population Prospects Report of United Nations published in 2017, an estimated 962 million people were aged 60 or over in the world (13 per cent of the global population) in 2017. The population aged 60 or above is growing at a rate of around 3% annually and it is estimated to reach 1.4 billion by 2030. Such high number of aging population would be immensely benefitted with smart healthcare products.


Key players operating in smart healthcare products market include Allscripts Healthcare Solutions Inc. Medtronic, Inc., Becton Dickinson & Company, Honeywell Life Care Solutions, AirStrip Technologies, Cerner Corporation, Stanley Healthcare, Terumo Corporation, Olympus Corporation, and eClinicalWorks.

 

 

Detailed Segmentation:


Global Smart Healthcare Products Market, By Product Type

Electronic Health Record

Smart Pill

Smart Syringes

RFID Systems

Other

Global Smart Healthcare Products Market, By Applications

Health Data Storage

Monitoring and Treatment

Inventory Management

Global Smart Healthcare Products Market, By Geography

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

 

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Shingles Vaccine Market - Trends, Outlook, and Opportunity Analysis, 2018-2026

The shingles vaccine market revenue is expected to grow at a robust rate over the forecast period. Shingles, also known as herpes zoster, is a viral infection that affects the cranial nerves that originate in the brain. It is caused by the varicella zoster virus, the same virus that also cases chicken pox. The virus can stay dormant for many years in the human body. Therefore, anyone who has had chicken pox in the past is at the risk of developing shingles. According to the Center for Disease Control and Prevention (CDC), there are an estimated one million cases of shingles reported every year in the U.S. Moreover, CDC states that around one in every three people in the U.S. will develop shingles in their lifetime. The risk of shingles increases with age, with most cases reported among people over 40 years old. This is mainly due to weakening of the immune system on account of increased stress and inadequate intake of essential nutrients to keep immunity strong.


For In depth Information Get Sample Copy of this Report @ https://bit.ly/2Nu4SMn


Symptoms include skin rashes, nerve pain, vision loss, chills, upset stomach, muscle weakness, skin infection, and scarring. Treatment for shingles includes antiviral medication—acyclovir, valacyclovir, and famciclovir. These medicines help shorten the length and alleviate the severity of the illness. Further, analgesics may help relieve the pain.


Shingles Vaccine Market Dynamics:


There is a safe and effective vaccines available for preventing shingles. The Zostavax vaccine licensed by Merck & Co., Inc. in 2006 is an effective vaccine against shingles. The vaccine is intended for use in population over 50 years of age. The trials of the Zostavax vaccine demonstrated that the vaccine was 64% effective in people aged 60 to 69 years. The effectiveness reduces with increasing age i.e. to 41% for the 70–79 age group, and 18% for those 80 years of age and older. The vaccine was launched in the India market in February 2016, at half the price of the U.S. market. Zostavax, among the only shingles vaccine in the market, recorded sales of US$ 749 million in 2015.


In October 2016, GlaxoSmithKline (GSK)—a global leader in vaccines market—filed for U.S. FDA approval for its shingles vaccine, Shingrix. Shingrix has demonstrated better outcomes than Zostavax in its clinical trials. The vaccine was 90% efficacious in people over 70 years of age. The overall effectiveness of the vaccine is found to be 97%. Its higher effectiveness even among elder group of people is projected to increase its adoption across the globe. The impressive trail results would put Shingrix in a strong competitive position in the global market, currently monopolized by Zostavax. The company is reported to have filed for regulatory approvals in the Europe and Canada markets in 2016, followed by Japan in 2017. It is estimated that the sales of Shingrix would reach US$ 1 billion by 2021.


Shingles vaccines market is witnessing rapid influx of newer and expensive products. The industry is consolidated in nature however, new entrants are expected to emerge in the near future.


Browse Complete Report For More Information @ https://bit.ly/2Nsl5lb



Shingles Vaccine Market Regional Analysis:


North America and Europe are expected to collectively account for a major share of the market between 2016 and 2024. North America market growth is primarily driven by rising demand in the U.S., while the market in Europe is expected to be driven by increased therapeutic demand from European Union.


Asia Pacific shingles vaccine market is expected to witness highest growth over the forecast period. There is a wide addressable market that needs to be capitalized upon in the region especially in China and India. Active marketing and differential pricing would help companies to strengthen their market presence in Asia Pacific.


Shingles Vaccine Market Opportunity:


Prevalence of shingles is increasing across the globe, fuelled mainly by increasing aging population. However, high cost of vaccines is limiting vaccination drive in emerging economies, characterized by inadequate insurance coverage. The major concern among healthcare experts is reduction in postherpetic neuralgia from the shingles vaccine. Zostavax has been successful to a certain extent in reducing postherpetic neuralgia due to the effect of the vaccine on reducing risk of developing herpes zoster. Better outcomes of Shingrix would be a boon for highly lucrative global shingles vaccines market.


Request For Customization of Research Report @ https://bit.ly/2U7ntjz

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com